Journal Mobile Options
Table of Contents
Vol. 28, No. 3, 2009
Issue release date: August 2009
Cerebrovasc Dis 2009;28:306–313

T2*-Weighted MRI versus Oxygen Extraction Fraction PET in Acute Stroke

Donswijk M.L. · Jones P.S. · Guadagno J.V. · Carpenter T.A. · Moustafa R.R. · Fryer T.D. · Aigbirhio F.I. · Warburton E.A. · Baron J.C.
aStroke Research Group and bWolfson Brain Imaging Centre, Department of Clinical Neurosciences and cStroke Unit, Department of Medicine, University of Cambridge, Cambridge, UK

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Mapping high oxygen extraction fraction (OEF) in acute stroke is of considerable interest to depict the at-risk tissue. Being sensitive to deoxyhemoglobin, T2*-weighted MRI has been suggested as a potential marker of high OEF. Methods: We compared T2*-weighted images from pre-contrast arrival perfusion scans against quantitative positron emission tomography in 5 patients studied 7–21 h after onset of carotid territory stroke. OEF and T2* signal were obtained in the voxels with significantly high OEF. Results: All patients showed increased OEF. No significant relationship between OEF and T2*-weighted signal was found either within or between subjects. Conclusion: We found no indication that T2*-weighted MRI in the way implemented in this investigation was sensitive to high OEF in acute stroke.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P: Reversal of focal ‘Misery-perfusion syndrome’ by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke 1981;12:454–459.
  2. Roussel SA, van Bruggen N, King MD, Gadian DG: Identification of collaterally perfused areas following focal cerebral ischemia in the rat by comparison of gradient echo and diffusion-weighted MRI. J Cereb Blood Flow Metab 1995;15:578–586.
  3. De Crespigny AJ, Wendland MF, Derugin N, Kozniewska E, Moseley ME: Real-time observation of transient focal ischemia and hyperemia in cat brain. Magn Reson Med 1992;27:391–397.
  4. Dijkhuizen RM, Berkelbach van der Sprenkel JW, Tulleken KA, Nicolay K: Regional assessment of tissue oxygenation and the temporal evolution of hemodynamic parameters and water diffusion during acute focal ischemia in rat brain. Brain Res 1997;750:161–170.
  5. Ogawa S, Lee TM, Nayak AS, Glynn P: Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 1990;14:68–78.
  6. Tamura H, Hatazawa J, Toyoshima H, Shimosegawa E, Okudera T: Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2*-weighted magnetic resonance imaging. Stroke 2002;33:967–971.
  7. Wardlaw JM, von Heijne A: Increased oxygen extraction demonstrated on gradient echo (T2*) imaging in a patient with acute ischaemic stroke. Cerebrovasc Dis 2006;22:456–458.
  8. Morita N, Harada M, Uno M, Matsubara S, Matsuda T, Nagahiro S, Nishitani H: Ischemic findings of T2*-weighted 3-tesla MRI in acute stroke patients. Cerebrovasc Dis 2008;26:367–375.
  9. Guadagno JV, Warburton EA, Jones PS, Day DJ, Aigbirhio FI, Fryer TD, Harding S, Price CJ, Green HA, Barret O, Gillard JH, Baron JC: How affected is oxygen metabolism in DWI lesions?: A combined acute stroke PET-MR study. Neurology 2006;67:824–829.
  10. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, Gillard JH, Williams GB, Aigbirhio FI, Warburton EA, Ostergaard L, Baron JC: How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke 2008;39:870–877.
  11. Smielewski P, Coles JP, Fryer TD, Minhas PS, Menon DK, Pickard JD: Integrated image analysis solutions for PET datasets in damaged brain. J Clin Monit Comput 2002;17:427–440.
  12. Grohn OH, Kettunen MI, Penttonen M, Oja JM, van Zijl PC, Kauppinen RA: Graded reduction of cerebral blood flow in rat as detected by the nuclear magnetic resonance relaxation time T2: a theoretical and experimental approach. J Cereb Blood Flow Metab 2000;20:316–326.
  13. Grohn OH, Lukkarinen JA, Oja JM, van Zijl PC, Ulatowski JA, Traystman RJ, Kauppinen RA: Noninvasive detection of cerebral hypoperfusion and reversible ischemia from reductions in the magnetic resonance imaging relaxation time, T2. J Cereb Blood Flow Metab 1998;18:911–920.
  14. Kavec M, Grohn OH, Kettunen MI, Silvennoinen MJ, Penttonen M, Kauppinen RA: Use of spin echo T(2) BOLD in assessment of cerebral misery perfusion at 1.5 T. MAGMA 2001;12:32–39.
  15. Ogawa S, Lee TM, Barrere B: The sensitivity of magnetic resonance image signals of a rat brain to changes in the cerebral venous blood oxygenation. Magn Reson Med 1993;29:205–210.
  16. Geisler BS, Brandhoff F, Fiehler J, Saager C, Speck O, Rother J, Zeumer H, Kucinski T: Blood-oxygen-level-dependent MRI allows metabolic description of tissue at risk in acute stroke patients. Stroke 2006;37:1778–1784.
  17. Fiehler J, Geisler B, Siemonsen S, Saager C, Speck O, Thomalla G, Grzyska U, Kucinski T: [Visual rating of T2’-blood-oxygen-level-dependent magnetic resonance imaging in acute stroke patients – a pilot study]. Rofo 2007;179:17–20.
  18. Siemonsen S, Fitting T, Thomalla G, Horn P, Finsterbusch J, Summers P, Saager C, Kucinski T, Fiehler J. T2’ imaging predicts infarct growth beyond the acute diffusion-weighted imaging lesion in acute stroke. Radiology 2008;248:979–986.
  19. Lee JM, Vo KD, An H, Celik A, Lee Y, Hsu CY, Lin W: Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients. Ann Neurol 2003;53:227–232.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50